Search

everythinglearnresearchcommunity

for

Search:↓

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

Combining medication for dyslipidemia and insulin resistance with basic therapy improves outcomes for alopecia areata with metabolic syndrome.

Alopecia areata costs individuals about 3% of their income, with women, Asians, those with lower income, and more severe symptoms spending more.

Oxidative stress is linked to mild patchy alopecia areata.

New treatment for hair loss using special microneedles shows promise in reducing inflammation and promoting hair growth.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

Baricitinib is a promising treatment for alopecia areata.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

The study suggests that analyzing DNA can help treat hair loss, but more research is needed.

Early recognition and treatment of atypical alopecia areata in infants are crucial.

Alopecia areata may be linked to hearing problems, so patients should monitor their hearing.

Lower vitamin D levels are linked to higher CRP levels in people with a type of hair loss called alopecia areata.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Raman spectroscopy is promising for measuring and enhancing drug delivery in alopecia treatments.

Platelet-Rich Plasma (PRP) may be a safe and effective treatment for hair loss caused by Alopecia Areata.

Adipose-derived stem cells may help with hair loss, but more research is needed.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

Measuring bald patch size can help grade hair loss severity, with photograph-based evaluation being more reliable.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

People with certain skin disorders are more likely to have alcohol problems, especially if they also have mental health issues like depression and anxiety.

CT60 polymorphism might increase the risk of Alopecia Areata.

DNA analysis can help tailor alopecia treatment.

Combining topical delgocitinib with a 308-nm excimer laser can effectively treat severe alopecia areata and vitiligo.

Certain gut bacteria may protect against alopecia areata, while others may increase the risk.